Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001746473-25-000003
Filing Date
2025-01-22
Accepted
2025-01-22 18:00:36
Documents
1
Period of Report
2025-01-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1737586829.html 4  
1 FORM 4 wk-form4_1737586829.xml 4 4110
  Complete submission text file 0001746473-25-000003.txt   5593
Mailing Address C/O PLIANT THERAPEUTICS, INC. 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Lefebvre Eric (Reporting) CIK: 0001614741 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 25547069

Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)